Insights

SBIR Funding Leverage Epivara's history of multiple SBIR grants and NSF backing to position long-term, grant-supported collaboration opportunities, including joint R&D programs, pilot studies, and government-funded trials that validate non-surgical sterilization methods.

Non-Surgical Solution Target shelters, farms, and veterinary clinics with Epivara’s iSpay/iNeuter as a cost-effective, single-injection alternative to invasive surgeries, highlighting faster deployment, reduced animal stress, and lower operational costs.

Social Impact Frame the product as a solution to animal overpopulation and welfare, aligning with nonprofit adoption groups and humane societies seeking scalable, humane sterilization options that also lower anesthesia risks and recovery time.

Growth Potential With revenues in a startup range and a notable grant-backed funding history, pursue partnerships with veterinary distributors, animal welfare NGOs, and agricultural suppliers to accelerate market entry and co-market the technology.

Tech & Compliance Highlight the ease of integration with existing clinic workflows and digital assets (QuickBooks, Cloud, eCommerce) to streamline purchasing, invoicing, and regulatory documentation, while showcasing a scalable tech-enabled service model.

Similar companies to Epivara

Epivara Tech Stack

Epivara uses 8 technology products and services including QuickBooks, Usercentrics, Wix, and more. Explore Epivara's tech stack below.

Media & News

Epivara's Email Address Formats

Epivara uses at least 1 email format:
Epivara Email FormatsExamplePercentage
First@epivara.comJohn@epivara.com
100%

Frequently Asked Questions

What is Epivara's official website and social media links?

Minus sign iconPlus sign icon
Epivara's official website is epivara.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Epivara generate?

Minus sign iconPlus sign icon
As of September 2026, Epivara's annual revenue is estimated to be $1M - $10M.

What is Epivara's NAICS code?

Minus sign iconPlus sign icon
Epivara's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Epivara have currently?

Minus sign iconPlus sign icon
As of September 2026, Epivara has approximately 13 employees across 1 continents, including North America. Key team members include Director Or Marketing And Brand: J. S. Explore Epivara's employee directory with LeadIQ.

What industry does Epivara belong to?

Minus sign iconPlus sign icon
Epivara operates in the Pharmaceutical Manufacturing industry.

What technology does Epivara use?

Minus sign iconPlus sign icon
Epivara's tech stack includes QuickBooks, Usercentrics, Wix, WordPress, Wix eCommerce, Google Workspace, Google Cloud and Sentry.

What is Epivara's email format?

Minus sign iconPlus sign icon
Epivara's email format typically follows the pattern of First@epivara.com. Find more Epivara email formats with LeadIQ.

How much funding has Epivara raised to date?

Minus sign iconPlus sign icon
As of September 2026, Epivara has raised $8.8M in funding. The last funding round occurred on Mar 18, 2025 for $4M.

When was Epivara founded?

Minus sign iconPlus sign icon
Epivara was founded in 2016.
Epivara logo

Epivara

Pharmaceutical ManufacturingIllinois, United States11-50 Employees

Epivara, a pharmaceutical manufacturing company based in Champaign, Illinois, focuses on humane, non-surgical methods for animal sterilization. Its flagship approach, iSpay and iNeuter, is designed to provide a simple, single-injection alternative to traditional spay/neuter procedures, with the aim of reducing animal discomfort and recovery time while offering a cost-effective solution for shelters, breeders, and farmers. The technology seeks to lower aggressive and sexual behaviors by suppressing hormone production, ultimately contributing to animal health, overpopulation control, and welfare in dogs, cats, and livestock.

Operating within the animal health and veterinary biotechnology sector, Epivara positions itself as a provider of innovative, non-invasive sterilization options that can be deployed across shelters, farms, and veterinary settings. The company has pursued early-stage research and development activities and has engaged with government-backed SBIR programs, reflecting its focus on advancing non-surgical sterilization methods for both female and male animals. Epivara has a presence in the U.S. market and emphasizes its rebranding from its former name, InSigna, while continuing to pursue its mission through scientific development and practical applications.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $8.8M

    Epivara has raised a total of $8.8M of funding over 5 rounds. Their latest funding round was raised on Mar 18, 2025 in the amount of $4M as a Venture Round.

  • $1M - $10M

    Epivara's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.